Handelsbanken Fonder’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-16,900
Closed -$298K 1566
2025
Q1
$298K Hold
16,900
﹤0.01% 1413
2024
Q4
$411K Hold
16,900
﹤0.01% 1367
2024
Q3
$628K Buy
16,900
+4,000
+31% +$149K ﹤0.01% 1145
2024
Q2
$614K Buy
12,900
+2,400
+23% +$105K ﹤0.01% 1065
2024
Q1
$402K Hold
10,500
﹤0.01% 1269
2023
Q4
$328K Buy
10,500
+1,600
+18% +$57.5K ﹤0.01% 1352
2023
Q3
$358K Hold
8,900
﹤0.01% 1225
2023
Q2
$468K Hold
8,900
﹤0.01% 1100
2023
Q1
$569K Buy
8,900
+1,700
+24% +$111K ﹤0.01% 946
2022
Q4
$349K Sell
7,200
-1,600
-18% -$100K ﹤0.01% 1166
2022
Q3
$621K Hold
8,800
﹤0.01% 846
2022
Q2
$624K Buy
8,800
+1,700
+24% +$110K ﹤0.01% 900
2022
Q1
$567K Sell
7,100
-2,100
-23% -$156K ﹤0.01% 1113
2021
Q4
$840K Hold
9,200
﹤0.01% 987
2021
Q3
$1.18M Hold
9,200
0.01% 818
2021
Q2
$1.4M Hold
9,200
0.01% 752
2021
Q1
$970K Buy
9,200
+1,600
+21% +$160K 0.01% 859
2020
Q4
$602K Hold
7,600
﹤0.01% 1058
2020
Q3
$430K Hold
7,600
﹤0.01% 1064
2020
Q2
$468K Buy
+7,600
New +$310K ﹤0.01% 991

Other funds holding STAA

Handelsbanken Fonder's STAA Position: Q2 2025 in Review

Handelsbanken Fonder sold out of STAAR Surgical (STAA) in Q2 2025, closing a stake of 16,900 shares — an estimated $298K sold.

Handelsbanken Fonder first reported a position in STAA in Q2 2020 and held it in 20 quarters. The position peaked at $1.4M in Q2 2021. 170 funds tracked by Wall St. Rank hold STAA as of Q2 2025.

  • Handelsbanken Fonder reported no remaining STAAR Surgical position as of Q2 2025 after selling out during the quarter.
  • Handelsbanken Fonder sold 16,900 STAAR Surgical shares in Q2 2025, an estimated $298K.
  • Handelsbanken Fonder first reported a position in STAAR Surgical in Q2 2020 and held it in 20 quarters.
  • Handelsbanken Fonder's STAAR Surgical position peaked at $1.4M in Q2 2021.
  • 170 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2025.

Based on Handelsbanken Fonder's 13F filing for Q2 2025, filed 12 Aug 2025.